• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (IRVINE) XEN 45 GTS; IMPLANT, EYE VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (IRVINE) XEN 45 GTS; IMPLANT, EYE VALVE Back to Search Results
Catalog Number 5513-001
Device Problem Defective Component (2292)
Patient Problem No Patient Involvement (2645)
Event Date 05/14/2019
Event Type  malfunction  
Manufacturer Narrative
A review of the device history record has been initiated.If any deviations or non-conformance's are found, a supplemental medwatch will be submitted.Serial number (b)(4), lot number 62812.Device labeling: precautions: the xen®45 gel stent and xen® injector should be carefully examined in the operating room prior to use.
 
Event Description
Healthcare professional reported needle was shorter than specification against the xen®45 gts.There was no patient contact.Surgery was completed with another xen.
 
Event Description
Healthcare professional reported needle was shorter than specification against the xen®45 gts.There was no patient contact.Surgery was completed with another xen.
 
Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.Device evaluation: the needle tip of the injector was measured against a certified ruler.The needle was measured at 3.5mm and were determined to be within the limits of the design specifications.For evaluation purposes in the irvine dal, the slider was tested for actuation.Results showed that slider knob was able to slide the full distance of the travel length, as tested multiple times in each of the three needle bevel selector positions.The functional testing showed that the pusher rod that pushes the gel stent out of the needle performed correctly and the needle retracted correctly as the slider knob was advanced to the end of the travel distance.The gel stent was not returned for further analysis.The reported complaint of the xen glaucoma treatment system was not confirmed.The returned unit needle tip was measured to be 3.5mm.There were no other anomalies observed.The manufactured xen systems are 100% tested in-process and inspected at manufacturing.Allergan will continue to monitor the frequency of these complaints to determine if there is a trend or if this was an individual occurrence.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XEN 45 GTS
Type of Device
IMPLANT, EYE VALVE
Manufacturer (Section D)
ALLERGAN (IRVINE)
2525 dupont drive
irvine CA 92612
MDR Report Key8746953
MDR Text Key149641294
Report Number3011299751-2019-00145
Device Sequence Number1
Product Code KYF
Combination Product (y/n)N
PMA/PMN Number
K161457
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 09/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2021
Device Catalogue Number5513-001
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/17/2019
Date Manufacturer Received08/28/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-